Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125274331 | 12527433 | 1 | I | 2010 | 20160617 | 20160705 | 20160705 | EXP | ES-ELI_LILLY_AND_COMPANY-ES201607000192 | ELI LILLY AND CO | 65.00 | YR | F | Y | 46.00000 | KG | 20160701 | CN | GB | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125274331 | 12527433 | 1 | PS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1000 MG/M2, CYCLICAL | U | 20509 | 1000 | MG/M**2 | |||||||
| 125274331 | 12527433 | 2 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 400 MG/M2, CYCLICAL | U | 20509 | 400 | MG/M**2 | |||||||
| 125274331 | 12527433 | 3 | SS | TEGAFUR | TEGAFUR | 1 | 1200 MG, QD | U | 0 | 1200 | MG | QD | |||||||
| 125274331 | 12527433 | 4 | SS | PACLITAX NAB | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 50 MG/M2, CYCLICAL | 0 | 50 | MG/M**2 | ||||||||
| 125274331 | 12527433 | 5 | SS | PACLITAX NAB | PACLITAXEL | 1 | 0 | ||||||||||||
| 125274331 | 12527433 | 6 | C | OXYCODONE | OXYCODONE | 1 | Oral | 40 MG, BID | 0 | 40 | MG | BID | |||||||
| 125274331 | 12527433 | 7 | C | OXYCODONE | OXYCODONE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125274331 | 12527433 | 1 | Adenocarcinoma pancreas |
| 125274331 | 12527433 | 3 | Adenocarcinoma pancreas |
| 125274331 | 12527433 | 4 | Metastases to bone |
| 125274331 | 12527433 | 5 | Pulmonary mass |
| 125274331 | 12527433 | 6 | Analgesic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125274331 | 12527433 | DE |
| 125274331 | 12527433 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125274331 | 12527433 | Anaemia | |
| 125274331 | 12527433 | Asthenia | |
| 125274331 | 12527433 | Biliary dilatation | |
| 125274331 | 12527433 | Biliary tract disorder | |
| 125274331 | 12527433 | Cholangitis | |
| 125274331 | 12527433 | Cholangitis acute | |
| 125274331 | 12527433 | Diabetes mellitus | |
| 125274331 | 12527433 | Diarrhoea | |
| 125274331 | 12527433 | Enteritis | |
| 125274331 | 12527433 | Hepatotoxicity | |
| 125274331 | 12527433 | Lymphopenia | |
| 125274331 | 12527433 | Neutropenia | |
| 125274331 | 12527433 | Oedema peripheral | |
| 125274331 | 12527433 | Pancreatic insufficiency | |
| 125274331 | 12527433 | Pyrexia | |
| 125274331 | 12527433 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125274331 | 12527433 | 1 | 201006 | 0 | ||
| 125274331 | 12527433 | 2 | 201311 | 0 | ||
| 125274331 | 12527433 | 3 | 201006 | 0 | ||
| 125274331 | 12527433 | 4 | 201311 | 0 |